Gedeon Richter PLC (BUD:RICHTER)

Market Cap	2.17T +11.2%
Revenue (ttm)	928.96B +8.3%
Net Income	232.34B -2.9%
EPS	1,271.00 -2.8%
Shares Out	182.38M
PE Ratio	9.35
Forward PE	7.97
Dividend	508.56 (4.43%)
Ex-Dividend Date	Jun 3, 2025

Volume	142,130
Average Volume	227,343
Open	11,800
Previous Close	11,810
Day's Range	11,710 - 11,940
52-Week Range	9,380 - 12,250
Beta	0.29
RSI	61.26
Earnings Date	Feb 27, 2026

About Gedeon Richter

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women’s lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic ...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 10,943
• Stock Exchange: Budapest Stock Exchange
• Ticker Symbol: RICHTER

Financial Performance

In 2025, Gedeon Richter's revenue was 928.96 billion, an increase of 8.33% compared to the previous year's 857.55 billion. Earnings were 232.34 billion, a decrease of -2.89%.